发明申请
US20100298210A1 HCV NS3 Protease Inhibitors 有权
HCV NS3蛋白酶抑制剂

HCV NS3 Protease Inhibitors
摘要:
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use treating or preventing HCV infections.
公开/授权文献
信息查询
0/0